Literature DB >> 4812988

Furosemide concentrations in serum and urine, and its binding by serum proteins as measured fluorometrically.

A W Forrey, B Kimpel, A D Blair, R E Cutler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4812988

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  10 in total

Review 1.  Diuretics: mechanism of action and clinical application.

Authors:  D L Davies; G M Wilson
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  The effect of frusemide on indomethacin plasma levels.

Authors:  P M Brooks; M A Bell; P Lee; P J Rooney; W C Dick
Journal:  Br J Clin Pharmacol       Date:  1974-12       Impact factor: 4.335

3.  Hemodialyzer clearances of gentamicin, kanamycin, tobramycin, amikacin, ethambutol, procainamide, and flucytosine, with a technique for planning therapy.

Authors:  T G Christopher; A D Blair; A W Forrey; R E Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

4.  Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure.

Authors:  F Andreasen; E Mikkelsen
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

Review 5.  Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

Authors:  L L Ponto; R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 6.  Clinical pharmacokinetics of frusemide.

Authors:  R E Cutler; A D Blair
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

7.  Protein binding of piretanide in normal and uraemic serum.

Authors:  H L Elliott; A F Ansari; B C Campbell; J R Lawrence
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Continuous infusion of frusemide in refractory oedema [proceedings].

Authors:  J M Gray; D A Henry; D H Lawson; W J Tilstone; H J Longman
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

9.  Clinical and pharmacological investigations of the new saluretic azosemid.

Authors:  F Krück; W Bablok; E Besenfelder; G Betzien; B Kaufmann
Journal:  Eur J Clin Pharmacol       Date:  1978-11-27       Impact factor: 2.953

10.  Kinetics of furosemide in children with chronic renal failure undergoing regular haemodialysis.

Authors:  E Riva; E Fossali; A Bettinelli
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.